KalVista Pharmaceuticals (KALV) Payables (2014 - 2025)
KalVista Pharmaceuticals (KALV) reported Payables of $5.9 million for Q3 2025, down 45.62% on a YoY basis from $10.8 million in Q3 2024, and up 20.19% sequentially from $4.9 million in Q2 2025.
KalVista Pharmaceuticals (KALV) Payables (2014 - 2025) Analysis & Trends
KalVista Pharmaceuticals (KALV) has 12 years of Payables data on file, last reported at $5.9 million in Q3 2025.
- For the quarter ending Q3 2025, Payables fell 45.62% year-over-year to $5.9 million; the trailing twelve-month figure through Jul 2025 stood at $5.9 million (down 45.62% YoY), and the FY2025 full-year result was $4.9 million, down 46.38% from the prior year.
- Payables grew to $5.9 million in Q3 2025, from $4.9 million in the prior quarter.
- In the past five years, Payables ranged from a high of $10.8 million in Q3 2024 to a low of $641000.0 in Q1 2021.
- A 5-year average of $4.2 million and a median of $3.6 million in 2022 frame the typical range for Payables.
- Across the five-year window, Payables tumbled 78.28% in 2021 and soared 240.87% in 2022, its largest moves.
- Tracing KALV's Payables over 5 years: stood at $3.2 million in 2021, then advanced by 7.12% to $3.4 million in 2022, then jumped by 44.68% to $4.9 million in 2023, then climbed by 16.95% to $5.7 million in 2024, then rose by 2.5% to $5.9 million in 2025.
- Business Quant data shows KALV's Payables at $5.9 million in Q3 2025, $4.9 million in Q2 2025, and $5.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | 5.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 5.87 Mn |
| Apr 30, 2025 | 4.88 Mn |
| Dec 31, 2024 | 5.73 Mn |
| Oct 31, 2024 | 5.20 Mn |
| Jul 31, 2024 | 10.79 Mn |
| Apr 30, 2024 | 9.11 Mn |
| Jan 31, 2024 | 3.10 Mn |
| Oct 31, 2023 | 4.90 Mn |
| Jul 31, 2023 | 5.06 Mn |
| Apr 30, 2023 | 4.82 Mn |
| Jan 31, 2023 | 1.70 Mn |
| Oct 31, 2022 | 3.38 Mn |
| Jul 31, 2022 | 2.91 Mn |
| Apr 30, 2022 | 3.64 Mn |
| Jan 31, 2022 | 2.19 Mn |
| Oct 31, 2021 | 3.16 Mn |
| Jul 31, 2021 | 1.45 Mn |
| Apr 30, 2021 | 1.98 Mn |
| Jan 31, 2021 | 641,000.00 |
| Oct 31, 2020 | 2.17 Mn |